UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of ~~September~~November, 2025

Commission File Number 001-40772

Cellebrite DI Ltd.

(Translation of registrant’s name into English)

94 Shlomo Shmelzer Road

Petah Tikva 4970602, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

On November 12, 2025, Cellebrite DI Ltd. (the “~~Company~~Registrant” or ~~the~~ “~~Registrant~~Cellebrite”) ~~hereby~~issued ~~announces~~a ~~that~~press ~~the~~release ~~shareholders~~titled of“Cellebrite ~~the Company approved all~~Announces ofThird-Quarter ~~the proposals brought before the annual general meeting of shareholders held on September 19,~~ 2025 ~~(the “Meeting~~Results.”~~), by~~ ~~the~~A ~~respective~~copy ~~requisite majority in accordance with the Israeli Companies Law, 5759-1999, and the Company’s articles~~ of ~~association, as~~this ~~described~~press inrelease ~~the Proxy~~is ~~Statement~~furnished ~~which was attached~~ as Exhibit 99.1 ~~to the Company’s Report of Foreign Private Issuer on Form 6-K, furnished to the Securities and Exchange Commission (the “SEC”) on August 15, 2025, and sent in connection with the Meeting~~herewith.

~~188,039,771~~The ~~ordinary~~GAAP financial statements tables contained in the press release ~~shares,~~attached ~~representing~~to ~~approximately~~this ~~76.82%~~report ofon Form 6-K are incorporated by reference into the ~~issued~~Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and ~~outstanding~~333-278130) ~~ordinary~~filed ~~shares~~with asthe ofU.S. Securities and Exchange Commission (the ~~record~~“SEC”) ~~date,~~on ~~were~~November ~~present~~8, or2021 ~~represented~~and byMarch ~~proxy~~21, at2024, respectively, and Form F-3 (File No. 333-259826) filed with the ~~Meeting~~SEC on September 13, 2022.

This Report on Form 6-K is incorporated by reference into the Registrant’s registration statements on Form S-8 (File Nos. 333-260878 and 333-278130) filed with the SEC on November 8, 2021 and March 21, 2024, respectively, and Form F-3 (File No. 333-259826) filed with the SEC on September 13, 2022.

~~SIGNATURES~~EXHIBIT INDEX

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Exhibit		Description
99.1		Press release titled “Cellebrite Announces Third-Quarter 2025 Results” (furnished herewith).

	Cellebrite DI Ltd.
September 22, 2025	By:	/s/ Ayala Berler Shapira
		Ayala Berler Shapira
		General Counsel

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Cellebrite DI Ltd.

Date: November 12, 2025	By:	/s/ David Barter
		David Barter
		Chief Financial Officer

Filing Compare · Cellebrite DI Ltd.